Triple Action Lotion – 30 ML

Icona London Triple Action Lotion 30 ML | Antifungal, Antibacterial & Anti-Inflammatory Topical Lotion with Betamethasone, Gentamicin, Tolnaftate & Iodochlorhydroxyquinoline

Icona London Triple Action Lotion – 30 ML is a topical dermatological preparation formulated with multiple active ingredients and presented with antifungal, anti-inflammatory and antibacterial positioning. The packaging identifies Betamethasone Dipropionate, Gentamicin Sulfate, Tolnaftate and Iodochlorhydroxyquinoline as components of the lotion, giving it a combination approach to appropriate skin-treatment applications.

The anti-inflammatory component, betamethasone dipropionate, belongs to the corticosteroid class. Topical betamethasone products are used to relieve inflammation and itching associated with corticosteroid-responsive skin disorders. Because corticosteroids can cause unwanted effects when used incorrectly, treatment area, quantity and duration should follow medical and product-label instructions.

The formula also lists Gentamicin Sulfate, an antibacterial antibiotic used topically against susceptible bacterial skin infections. This ingredient supports the antibacterial component of the Triple Action Lotion when bacterial involvement has been appropriately diagnosed.

Tolnaftate provides the product’s principal antifungal positioning. Official drug labeling identifies topical tolnaftate as an antifungal used for conditions such as athlete’s foot, ringworm and, in certain formulations, jock itch.

The packaging additionally lists Iodochlorhydroxyquinoline, commonly known as clioquinol. Clioquinol has been used topically for certain skin infections, including some fungal conditions. The exact concentration of this ingredient in Icona London Triple Action Lotion is To Be Confirmed.

The 200 ML bottle format provides a larger-volume option compared with smaller topical cream or lotion packs and may be convenient where medically directed application over an appropriate skin area is required. The bottle design also supports convenient dispensing and household or professional storage.

The packaging displays statements including “Complete Skin Solution,” “Result in 7 Days,” “Contact Dermatitis,” “Prevent Recurrence” and “Treat Fungal Infection.” These should be treated as packaging claims rather than guaranteed outcomes. Treatment response depends on the underlying condition, organism involved, severity, individual response and correct diagnosis.

For B2C users, this lotion should be used only according to the complete product instructions and appropriate healthcare-professional guidance. Fungal, bacterial and inflammatory skin conditions can sometimes look similar, and inappropriate use of a corticosteroid-containing combination may mask symptoms or complicate diagnosis.

For B2B buyers, Icona London Triple Action Lotion can be positioned for authorized pharmacies, healthcare distributors, pharmaceutical wholesalers, importers and regulated dermatology-product channels, subject to local registration and dispensing requirements.